Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Divestments: 2012-2025

  • BIO-TECHNE's Divestments fell 3.71% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 70.75%. This contributed to the annual value of $17.8 million for FY2023, which is N/A change from last year.
  • BIO-TECHNE's Divestments amounted to $1.4 million in Q3 2025, which was up 8.08% from $1.2 million recorded in Q1 2025.
  • BIO-TECHNE's Divestments' 5-year high stood at $17.8 million during Q3 2022, with a 5-year trough of $1.2 million in Q1 2025.
  • For the 3-year period, BIO-TECHNE's Divestments averaged around $1.5 million, with its median value being $1.4 million (2024).
  • Data for BIO-TECHNE's Divestments shows a maximum YoY plummeted of 87.94% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows BIO-TECHNE's Divestments stood at $17.8 million in 2022, then plummeted by 87.94% to $2.1 million in 2023, then slumped by 34.71% to $1.4 million in 2024, then dropped by 3.71% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.2 million for Q1 2025, and $1.4 million during Q3 2024.